Anlageziel Pharus SICAV - Medical Innovation Class A EUR Acc Fonds
This Sub-Fund aims to achieve growth by investing in equities or similar securities issued by biopharmaceutical companies that are at the forefront of innovation in the medical sector. The compartment will invest at least two-thirds of its total assets or wealth in equities issued by companies operating in this sector.
Stammdaten
| Valor | 33904956 |
| ISIN | LU1491986011 |
| Fondsgesellschaft | Pharus Management |
| Kategorie | Branchen: Biotechnologie |
| Währung | EUR |
| Mindestanlage | 94.84 |
| VL-fähig? | Nein |
| Thesaurierend/Ausschüttend | Thesaurierend |
| Fondsmanager |
Aktuelle Daten
| Fondsnote | |
| Aktueller Rücknahmepreis | 135.64 |
| Fondsvolumen | 1’437’000.65EUR |
| Total Expense Ratio (TER) | 3.21% |
Gebühren
| Verwaltungsgebühr | - |
| Depotbankgebühr | - |
| Rücknahmegebühr | 0.00 % |
| Ausgabeaufschlag | 3.00 % |